Albert David Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
2,867
3,166
3,186
2,921
2,849
Cost of Goods Sold (COGS) incl. D&A
2,053
2,408
2,315
2,138
2,185
Gross Income
815
757
871
783
664
SG&A Expense
596
548
609
547
489
EBIT
201
208
-
-
173
Unusual Expense
-
5
7
15
13
Non Operating Income/Expense
20
18
389
22
26
Interest Expense
39
30
21
9
10
Pretax Income
185
203
630
272
215
Income Tax
59
66
150
102
81
Consolidated Net Income
126
137
480
171
135
Net Income
126
137
480
171
135
Net Income After Extraordinaries
126
137
480
182
171
Net Income Available to Common
126
137
480
160
94
EPS (Basic)
22.03
24.01
84.10
27.96
17.24
Basic Shares Outstanding
6
6
6
6
6
EPS (Diluted)
22.03
24.01
84.10
27.96
17.24
Diluted Shares Outstanding
6
6
6
6
6
EBITDA
312
362
343
310
256
Other Operating Expense
17
2
9
1
1
Non-Operating Interest Income
2
2
2
10
14

About Albert David

View Profile
Address
'D' Block, 3rd Floor
Kolkata West Bengal 700001
India
Employees -
Website http://www.albertdavidindia.com
Updated 09/14/2018
Albert David Ltd. engages in the manufacture and trade of pharmaceuticals. Its products include a range of formulations, infusion solutions, bulk drugs, disposable syringes, and disposable needles. The company was founded in 1924 and is headquartered in Kolkata, India.